TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/18/25 10:38 | 7/17/25 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Freeman Kevin D | GA | D | P | 14 | 2.90 | 0 | 5 | 4 | 148 | D | |||||||||||||||
12/26/24 08:02 | 12/24/24 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Freeman Kevin D | GA | D | P | 8 | 0.8134 | 0 | 10 | 8 | 143 | D | |||||||||||||||
10/17/24 16:03 | 10/17/24 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Freeman Kevin D | GA | D | P | 3 | 2.64 | 0 | 1 | 1 | 133 | D | |||||||||||||||
10/16/24 16:12 | 10/16/24 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Freeman Kevin D | GA | D | P | 27 | 2.70 | 0 | 10 | 8 | 132 | M | |||||||||||||||
6/20/24 13:55 | 6/20/24 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Freeman Kevin D | GA | D | P | 6 | 2.38 | 0 | 3 | 2 | 122 | D | |||||||||||||||
4/22/24 16:04 | 4/22/24 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Freeman Kevin D | GA | D | P | 7 | 2.98 | 0 | 3 | 2 | 119 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |